Adipose tissue and atherosclerosis - Exploring the connection

被引:316
作者
Fantuzzi, Giamila
Mazzone, Theodore
机构
[1] Univ Illinois, Sect Endocrinol Diabet & Metab, Dept Human Nutr, Chicago, IL 60612 USA
[2] Univ Illinois, Dept Med, Chicago, IL 60612 USA
[3] Univ Illinois, Dept Pharmacol, Chicago, IL 60612 USA
关键词
obesity; atherosclerosis; adipocytokines; lipoprotein metabolism; visceral fat;
D O I
10.1161/ATVBAHA.106.131755
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The prevalence of obesity, especially among the young, is dramatically increasing in the United States. Obesity is associated with accelerated atherosclerosis and increased rates of cardiovascular death. There are many plausible mechanisms by which an increase in adipose tissue could adversely affect the vessel wall. These include the changes in blood pressure, glucose level, lipid/lipoprotein metabolism, and systemic inflammation. In addition, factors secreted by adipose tissue may directly influence vessel wall homeostasis by influencing the function of endothelial cells, arterial smooth muscle cells, and macrophages in the vessel wall. There is general agreement that central, as opposed to peripheral, adipose tissue confers the most cardio-metabolic risk. Although the basis of this differential risk has not been not established, the pattern of gene expression and secretory products in visceral fat would be predicted to be more atherogenic compared with that in subcutaneous peripheral fat. Numerous studies have shown the beneficial effects of weight loss on markers of cardiovascular risk but fewer have demonstrated improvement in direct measures of large vessel disease. The unfolding role of adipose tissue as an important metabolic and secretory organ provides new opportunities for developing more effective approaches for preventing obesity and its atherosclerotic complications.
引用
收藏
页码:996 / 1003
页数:8
相关论文
共 113 条
[1]   Effect of adiponectin on carotid arterial stiffness in type 2 diabetic patients treated with pioglitazone and metformin [J].
Araki, Takahiro ;
Emoto, Masanori ;
Teramura, Megumi ;
Yokoyama, Hisayo ;
Mori, Katsuhito ;
Hatsuda, Sawako ;
Maeno, Takaaki ;
Shinohara, Kayo ;
Koyama, Hidenori ;
Shoji, Tetsuo ;
Inaba, Masaaki ;
Nishizawa, Yoshiki .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2006, 55 (08) :996-1001
[2]   Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell [J].
Arita, Y ;
Kihara, S ;
Ouchi, N ;
Maeda, K ;
Kuriyama, H ;
Okamoto, Y ;
Kumada, M ;
Hotta, K ;
Nishida, M ;
Takahashi, M ;
Nakamura, T ;
Shimomura, I ;
Muraguchi, M ;
Ohmoto, Y ;
Funahashi, T ;
Matsuzawa, Y .
CIRCULATION, 2002, 105 (24) :2893-2898
[3]   Comparison of serum high-molecular weight (HMS adiponectin with total adiponectin concentrations in type 2 diabetic patients with coronary artery disease using a novel enzyme-linked immunosorbent assay to detect HMW adiponectin [J].
Aso, Yoshimasa ;
Yamamoto, Ruriko ;
Wakabayashi, Sadao ;
Uchida, Toshihiko ;
Takayanagi, Kan ;
Takebayashi, Kohzo ;
Okuno, Takehiko ;
Inoue, Teruo ;
Node, Koichi ;
Tobe, Takashi ;
Inukai, Toshihiko ;
Nakano, Yasuko .
DIABETES, 2006, 55 (07) :1954-1960
[4]   The effect of weight loss with or without exercise training on large artery compliance in healthy obese men [J].
Balkestein, EJ ;
van Aggel-Leijssen, DP ;
van Baak, MA ;
Struijker-Boudier, HA ;
Van Bortel, LM .
JOURNAL OF HYPERTENSION, 1999, 17 (12) :1831-1835
[5]   Surgical removal of visceral fat reverses hepatic insulin resistance [J].
Barzilai, N ;
She, L ;
Liu, BQ ;
Vuguin, P ;
Cohen, P ;
Wang, JL ;
Rossetti, L .
DIABETES, 1999, 48 (01) :94-98
[6]   Adipose tissue, inflammation, and cardiovascular disease [J].
Berg, AH ;
Scherer, PE .
CIRCULATION RESEARCH, 2005, 96 (09) :939-949
[7]  
Billington CJ, 2000, ARCH INTERN MED, V160, P898, DOI 10.1001/archinte.160.7.898
[8]   Changes of adiponectin oligomer composition by moderate weight reduction [J].
Bobbert, T ;
Rochlitz, H ;
Wegewitz, U ;
Akpulat, S ;
Mai, K ;
Weickert, MO ;
Möhlig, M ;
Pfeiffer, AFH ;
Spranger, J .
DIABETES, 2005, 54 (09) :2712-2719
[9]   Recombinant leptin promotes atherosclerosis and thrombosis in apolipoprotein E-deficient mice [J].
Bodary, PF ;
Gu, SF ;
Shen, YC ;
Hasty, AH ;
Buckler, JM ;
Eitzman, DT .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (08) :119-122
[10]   Leptin induces oxidative stress in human endothelial cells [J].
Bouloumié, A ;
Marumo, T ;
Lafontan, M ;
Busse, R .
FASEB JOURNAL, 1999, 13 (10) :1231-1238